Nasal Delivery Technology, Quality By Design Processes And Outsourcing Considerations
Source: Catalent

Catalent leverages decades of experience in the development, evaluation and manufacture of inhalation products to advance and accelerate molecules, from early development through commercial manufacturing. Catalent’s operation integrates its knowledge and experience to reliably deliver therapies across all common inhalation dosage forms including MDI, DPI and nasal sprays.
This eBook features articles discussing the advantages of unit/bi-dose nasal delivery technology, application of quality by design (QbD) process for inhaled product development and why companies are looking to outsource inhalation development and manufacturing.
VIEW THE E-BOOK!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Outsourced Pharma? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Catalent
This website uses cookies to ensure you get the best experience on our website. Learn more